Haleon (HLN) Accounts Payables (2021 - 2025)
Haleon (HLN) posted Accounts Payables of $5.0 billion for Q4 2025, up 95.93% on a QoQ basis from $2.5 billion in Q4 2024, and up 95.93% year-over-year from $2.5 billion in Q4 2024.
Haleon (HLN) Accounts Payables (2021 - 2025) Analysis & Trends
Haleon's Accounts Payables history runs 5 years deep, the most recent figure standing at $5.0 billion for Q4 2025.
- Quarterly Accounts Payables rose 95.93% year-over-year to $5.0 billion in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.0 billion (up 95.93% YoY) and the FY2025 annual result came in at $4.9 billion, up 95.0% from the prior year.
- Accounts Payables was $5.0 billion for Q4 2025 at Haleon, up from $2.5 billion in the prior quarter.
- Across five years, Accounts Payables topped out at $5.0 billion in Q4 2025 and bottomed at -$4.5 billion in Q2 2024.
- A 5-year average of $308.4 million and a median of $2.0 billion in 2021 frame the typical range for Accounts Payables.
- Annual changes were most pronounced in 2023 — Accounts Payables jumped 103.33% — and 2024, when it plunged 42.13%.
- Haleon's Accounts Payables stood at $1.8 billion in 2021, then rose by 16.63% to $2.2 billion in 2022, then surged by 103.33% to $4.4 billion in 2023, then plunged by 42.13% to $2.5 billion in 2024, then jumped by 95.93% to $5.0 billion in 2025.
- Business Quant data shows HLN's Accounts Payables at $5.0 billion in Q4 2025, $2.5 billion in Q4 2024, and -$4.5 billion in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 4.96 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 2.60 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 507.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.13 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 498.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 1.67 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.75 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 773.00 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 372.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | 58.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.96 Bn |
| Dec 31, 2024 | 2.53 Bn |
| Jun 30, 2024 | -4.54 Bn |
| Dec 31, 2023 | 4.38 Bn |
| Jun 30, 2023 | -4.39 Bn |
| Dec 31, 2022 | 2.15 Bn |
| Jun 30, 2022 | -4.47 Bn |
| Dec 31, 2021 | 1.85 Bn |